This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McNally, E. M. Search for Related Content PubMed PubMed Citation Articles by McNally, E. M.

(Circulation Research. 2002;90:246.)
© 2002 American Heart Association, Inc.

Editorials

ß-Myosin Heavy Chain Gene Mutations in Familial Hypertrophic Cardiomyopathy

The Usual Suspect?

Elizabeth M. McNally

From the University of Chicago, Departments of Medicine and Human Genetics, Chicago, Ill.

Correspondence to Elizabeth McNally, MD, PhD, Section of Cardiology, 5841 S Maryland, MC6088, Chicago, IL 60637. E-mail emcnally@medicine.bsd.uchicago.edu

Key Words: hypertrophic cardiomyopathy • myosin • light meromyosin • thick filament • mutation

Familial hypertrophic cardiomyopathy (FHC) is a genetic disorder arising from mutations in sarcomeric protein genes. Human genetic studies have implicated at least 9 different genes in FHC, emphasizing the enormous genetic and allelic heterogeneity associated with FHC.¹ ß-Myosin heavy chain (ßMyHC, MYH7) is the most commonly mutated gene in FHC, and at least 60 different MYH7 gene mutations have been described in human FHC subjects.² The vast majority of these are single base pair mutations that produce missense amino acid substitutions. Myosin is a hexamer composed of 2 heavy chains and 2 each of the regulatory and essential light chains (see Figure). Myosin is a highly asymmetric protein with a long rod domain and 2 globular heads. The globular domain of myosin, heavy meromyosin (HMM), can be proteolyzed into subfragment 1 (S1) and subfragment 2 (S2). The S1 head is the enzymatic "business" end of the molecule in that it possesses actin-activated ATPase activity and is capable of directing the sliding of actin filaments in vitro. The crystal structure of S1 has been determined, shedding light on the potential conformational changes that occur in response to ATP hydrolysis and that ultimately are responsible for myocyte shortening, skeletal muscle movement, and the beating of our hearts.³ Myosin was one of the first proteins to be purified and proteolytically separated into distinct functional domains contributing to the domain theory of proteins. Similarly for human genetic studies, the domain structure of myosin has proved useful because all the reported missense mutations . . . [Full Text of this Article]

This article has been cited by other articles:

				S. Bohlega, S. N. Abu-Amero, S. M. Wakil, P. Carroll, R. Al-Amr, B. Lach, Y. Al-Sayed, E. J. Cupler, and B. F. Meyer Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy Neurology, May 11, 2004; 62(9): 1518 - 1521. [Abstract] [Full Text] [PDF]